News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Sameer Rastogi Shared Early Results from SORASTOP Trial on Discontinuing Sorafenib in Desmoid Tumors
Sameer Rastogi/X
May 31, 2025, 12:57

Sameer Rastogi Shared Early Results from SORASTOP Trial on Discontinuing Sorafenib in Desmoid Tumors

Sameer Rastogi, Additional Professor of Sarcoma and GIST Medical Oncology Clinic at AIIMS, New Delhi, shared a post on X:

“We are pleased to share the preliminary results of SORASTOP, which investigates whether sorafenib can be discontinued in individuals with desmoid tumors who are responding to treatment. Good early results.”

Title: Clinico-radiological outcomes of desmoid type-fibromatosis after discontinuing the sorafenib treatment in responders – early results from the SORASTOP study

Authors: Bharath B Gangadharaiah, Ghazal Tansir, Sameer Rastogi, Simran Kaur, Vikas Garg, Ekta Dhamija, Adarsh Barwad, Shivanand Gamanagatti, Sandeep Bhoriwal and Maroof A Khan

Read Full Article on ecancer.

SORASTOP

Further Reading:

Sorafenib (Nexavar): Uses in Cancer, Side Effects, Dosage, Expectations, and More

Sorafenib (Nexavar): What patients need to know?

Sorafenib (Nexavar) on OncoDaily
Adarsh Barwad Bharath B Gangadharaiah cancer Ekta Dhamija Ghazal Tansir Maroof A Khan OncoDaily Oncology Sameer Rastogi Sandeep Bhoriwal Shivanand Gamanagatti Simran Kaur SORASTOP Trial Vikas Garg
Special Coverage
Science
May 31, 2025, 12:57
Sameer Rastogi Shared Early Results from SORASTOP Trial on Discontinuing Sorafenib in Desmoid Tumors
Blog
May 31, 2025, 12:52
Fumiko Ladd Chino: Seeing Friends, Colleagues, and Collaborators Who Live in Other Places is The Best Part of ASCO
Career
May 31, 2025, 12:32
Margarita Dionysiou Awarded St. Baldrick’s Fellowship for Leukemia Research - Johns Hopkins Kimmel Cancer Center
Blog
May 31, 2025, 12:22
Giselle Sholler: The Best Part about ANR is Connecting with Friends and Colleagues, New and Old
Insight
May 31, 2025, 12:13
E. Shyam P. Reddy: Researchers Identified a New Biomarker to Predict Outcomes in KRAS G12C-Mutated NSCLC
Oncolibrary
May 31, 2025, 11:53
KANDLELIT-001 Trial Demonstrates Promising Activity of MK-1084 in KRAS G12C–Mutant Colorectal Cancer at ASCO 2025
Blog
May 31, 2025, 11:32
Jame Abraham: Looking Forward to Seeing You at ASCO 2025 in Chicago
Blog
May 31, 2025, 11:04
Paolo Tarantino: Interesting Results From a 1L Trial of CDK4/6 Inhibitors in Triple-Positive MBC at ASCO 2025
Insight
May 31, 2025, 10:50
Sampson Chinonso Ipiankama: Proud to Share Our ASCO 2025 Abstract from Nigeria’s First National Study on Psycho-Oncology
Blog
May 31, 2025, 10:23
Sumanta Pal: Alexis Levee is Honored with ASCO Young Investigator Award
Oncolibrary
May 31, 2025, 10:22
CheckMate 8HW Trial at ASCO 2025: Nivolumab Plus Ipilimumab Sets New Standard for MSI-H/dMMR Metastatic Colorectal Cancer
Blog
May 31, 2025, 10:21
On World No Tobacco Day, CancerWorld Takes Aim at On-Screen Smoking